FDA recall record

Vintage Pharmaceuticals LLC, DBA Qualitest AMPICILLIN CAPSULES, USP, 250 mg, 500 count recall — FDA D-1350-2015

Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.

Class IIIclassification
D-1350-2015official record ID
Aug 26, 2015report date

Recall record at a glance

Official recordD-1350-2015
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmVintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals
Report dateAug 26, 2015
Recall initiation dateAug 13, 2015
Quantity360 Bottles
LocationHuntsville, AL, United States

Official product description

AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50

Why the product was recalled

Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.

Distribution information

U.S. Including: OH

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Telephone.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.